Cardiovascular

Educational resources

DVT and PE_prescribers checklist

Xarelto▼ (rivaroxaban) patient counselling checklist for HCPs—initiating, or transitioning to rivaroxaban for eligible patients with DVT or PE*

Commissioned by Bayer plc

Information intended for healthcare professionals. This checklist was developed from content provided by Bayer plc and the format was developed by Guidelines. Please see the bottom of the page for full disclaimer.

Pharmacist NVAF counselling checklist_interactive PDF

Community Pharmacist Counselling Checklist for patients with NVAF initiated on Xarelto▼ (rivaroxaban)

Commissioned by Bayer plc

Information intended for healthcare professionals. This checklist was developed from content provided by Bayer plc and the format was developed by Guidelines for Pharmacy. Please see the bottom of the page for full disclaimer.

NVAF prescribers checklist

Xarelto▼ (rivaroxaban) patient counselling checklist for HCPs—initiating, or transitioning to rivaroxaban for stroke prevention in patients with NVAF*

Commissioned by Bayer plc

Information intended for healthcare professionals. This checklist was developed from content provided by Bayer plc and the format was developed by Guidelines. Please see the bottom of the page for full disclaimer.

doctor with elderly man

Consensus guideline on the holistic management of patients requiring anticoagulation

By Working party–Fay Antoniou Martins Merriman Patrickson Uprichard

This guideline was developed by a multidisciplinary expert panel: Fay M et al with the support of a grant from Bayer plc.

Image of first page of NICE TA card

NICE Technology Appraisal 607: Rivaroxaban for preventing atherothrombotic events in people with coronary or peripheral artery disease

Commissioned by Bayer plc

The production of this Guidelines card has been commissioned by Bayer plc. Bayer plc has reviewed the card for technical accuracy and regulatory compliance and supplied the prescribing information.